Literature DB >> 19727621

Hypothesis-driven screening.

Ulrich Schopfer1, Caroline Engeloch, Frank Höhn, Hervé Mees, Jennifer Leeds, Fraser Glickman, Günther Scheel, Sandrine Ferrand, Peter Fekkes, Martin Pfeifer.   

Abstract

Phenotypic chemogenomics studies require screening strategies that account for the complex nature of the experimental system. Unknown mechanism of action and high frequency of false positives and false negatives necessitate iterative experiments based on hypotheses formed on the basis of results from the previous step. Process-driven High Throughput Screening (HTS), aiming to "industrialize" lead finding and developed to maximize throughput, is rarely affording sufficient flexibility to design hypothesis-based experiments.In this contribution, we describe a High Throughput Cherry Picking (HTCP) system based on acoustic dispensing technology that was developed to support a new screening paradigm. We demonstrate the power of hypothesis-based screening in three chemogenomics studies that were recently conducted.

Mesh:

Substances:

Year:  2009        PMID: 19727621     DOI: 10.1007/978-1-60761-274-2_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  In vitro and in vivo activities of novel, semisynthetic thiopeptide inhibitors of bacterial elongation factor Tu.

Authors:  J A Leeds; M J LaMarche; J T Brewer; S M Bushell; G Deng; J M Dewhurst; J Dzink-Fox; E Gangl; A Jain; L Lee; M Lilly; K Manni; S Mullin; G Neckermann; C Osborne; D Palestrant; M A Patane; A Raimondi; S Ranjitkar; E M Rann; M Sachdeva; J Shao; S Tiamfook; L Whitehead; D Yu
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.